Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway
In conclusion, TEC improves cardiac fibrosis in DCM mice by modulating the AdipoR1/AMPK signaling pathway. These findings suggest that TEC could be an effective therapeutic agent for the treatment of diabetic cardiomyopathy.PMID:38636400 | DOI:10.1016/j.biopha.2024.116589
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Yu-Lan Ma Man Xu Xian-Feng Cen Hong-Liang Qiu Ying-Ying Guo Qi-Zhu Tang Source Type: research
More News: Cardiology | Cardiomyopathy | Diabetes | Diets | Drugs & Pharmacology | Endocrinology | Heart | Heart Failure | High Fat | Hypertension | Nutrition | Study